(Q35115403)

6 August 2017

1 reference

title

Hormone replacement therapy and risk of breast cancer: the role of progestins. (English)

1 reference

6 August 2017

3

Elsebeth Lynge

1 reference

6 August 2017

Claudia Stahlberg

1

1 reference

6 August 2017

Anette Tønnes Pedersen

series ordinal

2

1 reference

6 August 2017

Bent Ottesen

series ordinal

4

1 reference

6 August 2017

publication date

1 April 2003

1 reference

Acta Obstetricia et Gynecologica Scandinavica

6 August 2017

published in

1 reference

6 August 2017

volume

82

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

335-344

1 reference

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

A comparative study of prescribing of hormone replacement therapy in USA and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Low use of long-term hormone replacement therapy in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Trends in the use of climacteric and postclimacteric hormones in Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Hormone replacement therapy and breast cancer: a qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

A population-based cohort study of HRT use and breast cancer in southern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Mammographic density changes during different postmenopausal hormone replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

The etiopathogenesis of breast cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Time since childbirth and prognosis in primary breast cancer: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Risk factors for breast cancer in women under 40 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

HRT and breast cancer risk: a clue for interpreting the available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Estrogen receptors and cell proliferation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy: patterns of use studied through British general practice computerized records

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy and risk of non-fatal stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy: knowledge, attitudes, self-reported use - and sales figures in Nordic women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Menopausal hormones and breast cancer in a biracial population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Hormone replacement therapy and breast cancer risk in a nationally representative cohort

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Mammographic changes in postmenopausal women on hormonal replacement therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Mammographic breast density during hormone replacement therapy: differences according to treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

A correlative morphologic study of human breast and endometrium in the menstrual cycle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Transient Increase in the Risk of Breast Cancer after Giving Birth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Progestins and breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Progestins and antiprogestins in mammary tumour growth and metastasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0412.2003.00055.X

7 January 2021

10.1034/J.1600-0412.2003.00055.X

Identifiers

DOI

1 reference

6 August 2017

1 reference